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Abstract
Objective: To evaluate the incidence, the impact on survival and the predictive factors of bile leakage
(BL) in a recent large monocentric series of liver resections performed in a referral tertiary care centre.
Background: Previous reports dealing with bile leakage (BL) after liver resection are rare and have
displayed conflicting results regarding incidence, impact on follow-up and predictive factors.
Methods: A retrospective review of the records of 912 patients who underwent a total of 1001 con-
secutive liver resections without biliary reconstruction, performed between January 2005 and May 2011.
BL was defined by the presence of bile in the abdominal drains, a radiologically or surgically drained
bilioma or biliary peritonitis. BL severity was established according to the Clavien–Dindo classification.
Fifty-eight pre-, per- and post-resection variables were analysed and the independent BL predictive
factors were identified using logistic regression.
Results: The incidence of BL was 8%. Clavien–Dindo I-II, IIIa, IIIb or IV rates were 29%, 35%, 32.5% and
2.5%, respectively. BL did not increase in-hospital mortality (2.5% versus 2.9%, P = 1.0), but doubled the
median duration of hospital stay (16 versus 9 days, P < 0.001) and increased 1-year mortality (11% versus
5%, P = 0.03). Multivariate analysis identified that pre-operative bevacizumab [odds ratio (OR) = 2.9,
confidence interval (CI) 95% = 1.58–5.41] P = 0.001], a major hepatectomy [OR = 2.6 (CI 95% = 1.48–4.76)
P = 0.001], a two-stage hepatectomy [OR = 2.5 (CI 95% = 1.17–5.52) P = 0.018], the selective clamping
technique [OR = 2.6 (CI 95% = 1.03–6.78) P = 0.042], R1 or R2 resection [OR = 2.6 (CI 95% = 1.52–4.64)
P = 0.001] and the absence of a methylene blue test [OR = 2.6 (IC 95% = 1.43–4.65) P = 0.002] were
independent risk factors of BL.
Conclusion: BL remains frequent after liver resection. It has a dramatic impact on patient survival and
care costs. Its incidence could be reduced by avoiding the pre-operative use of bevacizumab, avoiding
selective clamping and performing a blue dye test in all resections.
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Introduction
In the last decade, thanks to advances in surgical and peri-
operative management, liver surgery has made considerable
progress underpinned by the reduction in peri-operative morbid-
ity and mortality rates which are now below 45 % and 5%, respec-
tively, in most series.1,2
Among the complications of hepatic resection, bile leakage
(BL) remains a serious problem. It promotes sepsis,3 prolongs
hospitalization and may increase the cost of care. Recent series of
hepatectomies without biliary anastomosis reported a BL inci-
dence of between 3.6% and 10%.4–8
In recent years, the indications for resection of colorectal cancer
liver metastases (CRLM) have increased. The requirements for
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radical resection consist of larger and more complex resections,
almost always including chemotherapy whose impact on post-
hepatectomy morbidity has been demonstrated.9 The incidence of
BL remains unclear in these patients while it delays the initiation
of adjuvant therapy and may therefore alter the oncological
outcome, although this has not yet been proven.
The aim of this study was to analyse the impact of BL on
survival and identify the risk factors associated with BL in the
modern age of liver resection in a referral tertiary care centre.
Special attention was paid to CRLM.
Patients and methods
A retrospective analysis of patients undergoing partial hepatecto-
mies without biliary anastomosis between January 2005 and May
2011 at the Department of Hepatobiliary and Digestive Surgery at
Rennes University Hospital was performed. Local institutional
review board approval was obtained.
BL assessment
BL was assessed in three different clinical situations: (i) the pres-
ence of bile in the abdominal drains when present; (ii) percuta-
neous or surgical drainage of a biloma, i.e. collection adjacent to
the liver parenchymal cut surface as diagnosed by ultrasound or
CT scan and bringing back bile after percutaneous drainage (PD);
and (iii) biliary ascites or peritonitis found at laparotomy. BL were
classified according to the International Study Group of Liver
Surgery (ISGLS).10 The severity of BL was classified according to
the Clavien–Dindo classification.11
Surgical procedures
The surgical approach was almost always a laparotomy with a
J-shaped right subcostal incision. An ultrasound was always per-
formed per-operatively. Continuous or intermittent pedicle
clamping (Pringle manoeuvre) or selective clamping of the pedi-
cles for the segment to be resected were mostly performed. Portal
and suprahepatic pedicles were cut transparenchymally except
when the tumour had a close relationship with the origin of the
right or left portal pedicles. In this situation, intra glissonian dis-
section was first performed for immediate section of the artery
and portal vein. With very few exceptions, a parenchymal transec-
tion was performed using an ultrasonic dissector. Vessels or bile
ducts encountered during the transection were coagulated,
clipped or ligated according to their size. Electrocautery or argon
beamers were used for additional raw surface haemostasis when
necessary. Topical haemostatic agents such as fibrinogen-coated
collagen patches or fibrin glues were rarely applied to the paren-
chymal cut surface. An intra-operative methylene blue test was
commonly performed through a trancystic tube (C-tube) in order
to detect BL. The C-tube was left in position and externalized
through the skin. It was clamped on the fifth post-operative day in
the absence of BL and removed after 4 to 6 weeks in the outpatient
clinic. Cholangiography with distal clamping was performed after
surgery in case of doubt on the integrity of the biliary tract of the
liver remnant.
Two closed-suction drains (pressure -700 to -950 mbar) were
placed in the resection space and removed on the fifth post-
operative day when drainage was minimal, serous and not bile
stained. Outpatient monitoring with CT was performed at 30
days.
Definitions
Chemotherapy was considered recent if it was administered
during the year prior to a hepatectomy. A period of 3 weeks and 6
to 8 weeks was mandatory between surgery and non-targeted or
targeted chemotherapy, respectively.
Post-operative liver dysfunction became a failure when the
‘50-50 criteria’ were met (serum bilirubin level above 50 mmol/l
and prothrombin time less than 50% on day 5 after surgery).12
The nomenclature of segments and types of hepatectomies per-
formed followed ‘The Brisbane 2000 Terminology’.13 In this
setting, a major hepatectomy was defined as resection of at least
three liver segments and a minor resection was defined as resec-
tion of fewer than three segments, including a wedge resection.
Data collection and statistical analysis
Data collection was carried out to meet the main objective of the
predictive analysis of BL. It consisted of 58 pre-operative, intra-
operative or post-operative parameters.
Data were described by means and standard deviations for
quantitative variables and by absolute and relative frequencies for
qualitative variables. Median and range were used to describe the
time data. First, the characteristics of both groups defined by the
presence or the absence of post-operative BL were compared.
Wilcoxon’s rank-sum test was used to compare quantitative
parameters and Fisher’s exact test to compare qualitative param-
eters. Subsequently, all variables univariately significantly associ-
ated with the presence of BL with P < 0.2 were presented stepwise
to a multiple logistic regression model to assess their independent
link with BL status. Significant risk factors were selected with a
forward strategy using likelihood ratio statistics, with P = 0.05 on
the criterion level of selection. First, the selection was separately
performed by block according to the three groups of parameters
(pre-, intra- and post-operative factors). The final selection of
each block-selected variable was performed a second time to com-
plete the multivariate analysis. Statistical analyses were performed
with SPSS Statistics 17.0 software for Windows (SPSS Inc.,
Chicago, IL, USA).
Results
The analysis included 1001 consecutive resections performed in
912 patients (68.6% men and 31.4% women). Two, three, four or
five successive resections were performed in 70, 6, 1 and 1 patients,
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respectively. Patient characteristics and an indication for hepate-
ctomies are summarized in Tables 1 and 2.
During the study period, 62 hepatectomies were performed in
38 patients in a two-stage strategy. The indication for this proce-
dure was metastatic colorectal cancer except in two patients who
had two hepatectomies for multiple bilobar hepatocellular adeno-
mas and metastases of a gastrointestinal stromal tumour, respec-
tively. In 17 out of 36 patients, a colorectal resection was combined
with a first-stage hepatectomy (Table 3).
Incidence and characteristics of bile leakage
The incidence of BL was 8% (80/1001). The results are presented
in Table 4. A median of 157 hepatectomies (range: 54–175) were
performed yearly and the rate of BL was not different vis-à-vis the
year of liver resection (P = 0.63) (Fig. 1).
The classification and severity of BL are reported in Table 5.
BL healed with a median duration of 26 days (range: 1–153). In
the group of BL diagnosed as the presence of bile in the surgical
drain, 23 out of 37 had spontaneous healing after a median period
of 14 days (range, range: 1–73). In this group, an endoscopic
procedure and percutaneous drainage were necessary for 11 out of
37 and 3 out of 37 resections, respectively. The median duration of
biloma healing after percutaneous drainage was 31 days (range:
3–150).
For patients who had a hepatectomy without BL, the median
overall duration of hospitalization was 9 days (range: 1–113). It
was longer in BL patients [16 days, (range: 9, 91) (P < 0.001)]. For
non-BL and BL patients, hospital mortality rates were 2.9% and
2.5%, respectively (NS). As compared with non-BL patients, the
overall 1-year survival rate was significantly lower in BL patients
(89% versus 94.5%, P = 0.035).
The overall morbidity rate was 41.3% (413/1001). Various post-
operative complications are reported in Table 6. In the BL group,
40% of the patients had at least one associated complication.
Predictive factors for bile leakage
The factors associated with bile leak on univariate analysis are
shown in Table 7.
Among the 26 out of 62 two-stage hepatectomies which com-
pleted the surgical procedure with curative intent, the median
time between the first and second stages was 3.2 months (range:
1.8–11.8). BL occurred in 9 out of 26 two-stage hepatectomies, 4
out of 26 after the first stage and 5 out of 26 after the second stage.
Among the 652 anatomical resections, 227 were right hepatec-
tomies and 24 were left hemi-hepatectomies. The Hanging
manoeuvre was performed in 93 out of 251 patients who under-
went a right or left hepatectomy.
The BL rate was not different depending on whether or not this
manoeuvre was used to cut the liver parenchyma (P = 0.173).
The results of the multivariate analysis are reported in Table 8.
Discussion
The aim of this study was focused on the incidence and predictive
factors of BL after hepatic resection without biliary anastomosis.
Table 1 Patient characteristics
Patient characteristics
Age (years) (median) 64 [16;90]
Age 75 n (%) 152 (15.2)
Gender n (%)
Female 318 (31.8)
Male 683 (68.2)
BMI (kg/m2) (median) 25 [14;57]
Pre-operative cirrhosis n (%) 120 (12)
Child–Pugh A 120 (11.5)
Child–Pugh B 2 (0.2)
BMI, body mass index.
Table 2 Indications for hepatectomies
Indication for
hepatectomies
n (%)
Metastatic liver tumour 504 (50.3)
Colorectal metastasis 428 (42.7)
Other liver metastasis 76 (7.6)
Primary liver tumours 497 (49.7)
Hepatocellular carcinoma 276 (27.6)
Cholangiocarcinoma 68 (6.8)
Other malignancies 31 (3.1)
Benign liver lesion 122 (12.2)
Table 3 Pre-operative treatment for metastatic tumours
Pre-operative treatment for metastatic tumours (n = 504)
Chemotherapy 430 (85.3%)
Long-standing chemotherapy 64 (12.7%)
Recent chemotherapy 366 (72.6%)
Bevacizumab 93 (18.4%)
Cetuximab 48 (9.5%)
Table 4 Characteristics of bile leakage
Bile leakage 80/1001 (8%)
Median time between operation and BL 8.5 days [1;90]
Diagnosis
• Bile into the abdominal drain 37/80 (46%)
• Biloma 42/80 (53%)
Clinical presentation:
Fever 27/42
Abdominal pain 4/42
Both fever and abdominal pain 7/42
Incidentally 4/42
• Biliary peritonitis 1/80 (<1%)
BL, bile leakage.
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It covered a recent and large population of operated patients, at a
time when liver surgery has been enriched by sophisticated
techniques such as, two-stage surgery, repeat hepatectomy and
involving chemotherapy whose hepato-toxic effects have been
demonstrated.14 This study has shown that BL is still common,
lengthens the duration of hospitalization, increases morbidity and
is associated with a reduced 1-year survival.
The complexity of strategies, i.e. two-stage hepatectomies and
major resection, R1 or R2 resection, and the use of bevacizumab
in patients with colorectal liver metastasis, were independent risk
factors for developing a bile leak. The use of the methylene blue
test was shown to be effective in reducing the incidence of BL;
however, this finding should be tempered by the fact that patients
who had a second resection may not have had a blue test at the
time of the second set.
The present study is the first to show a reduction in patient
survival when BL occurs. This could be as a result of the fact that
CRLM were in high proportion and that BL could delay the ini-
tiation of adjuvant therapy and therefore worsen the prognosis.
Another study is being performed to confirm this supposition.
Half of the hepatectomies performed during the study period
were indicated to resect metastatic disease, the majority of which
were from colorectal cancer. Peri-operative chemotherapy strate-
gies have become frequent in the treatment of CRLM. Pre-
operative chemotherapy with bevacizumab has never been shown
to increase overall morbidity.15–18 In the present study, the BL rate
was significantly increased when patients received bevacizumab
pre-operatively. Although we cannot support this statement with
evidence, we suggest that the antiangiogenic effect of bevacizu-
mab could have delayed the healing of minor bile leakage.
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Figure 1 Incidence of bile leakage related to the year of surgery
Table 5 Severity of bile leakage
Classification n (%)
Clavien-Dindo
I 6 (7.5)
II 17 (21.2)
IIIa 28 (35)
IIIb 26 (32.5)
Iva 2 (2.5)
IVb 0 (0)
V 1 (1.3)
ISGLS
A 6 (7.5)
B 62 (77.5)
C 12 (15)
ISGLS, International Study Group of Liver Surgery.
Table 6 Overall post-operative complications
n (%) Without
BL
(n = 921)
With BL
(n = 80)
P
Overall morbidity 413 (41.3) - - -
Bile Leakage 80 (8) - - -
Other type of complication 333 (33.3) 300 33 0.137
Hepatic failure 29 (2.9) 24 5 0.074
Intra-abdominal bleeding 37 (3.7) 35 2 0.762
Intra-abdominal abscess 46 (4.6) 41 5 0.406
Abdominal wall abscess 9 (0.9) 8 1 0.529
Gastrointestinal leakage 11 (1.1) 10 1 0.6
Ascites 41 (4.1) 39 2 0.766
Pulmonary complication 65 (6.5) 56 9 0.092
Urinary complication 28 (2.8) 25 3 0.484
Thrombo-embolic
complication
15 (1.5) 8 7 <10-3
Infectious complication 52 (5.2) 47 5 0.830
BL, bile leakage.
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As far as a two-stage hepatectomy for metastases is concerned,
the Princeps study by Adam et al.19 did not report BL among the
post-operative complications. Since then, only four other studies
reporting the results of two-stage hepatectomies have considered
BL20–23 and none of them reported BL after the first stage.
However, BL after the second stage ranged from 2.6% to 21%. As
compared with these data, although the incidence of leakage after
the second hepatectomy was similar, the current rate of BL after
the first hepatectomy was higher than previously reported. This
may be because of the fact that our strategy was to achieve radical
resection of liver remnant metastases rather than use local
destruction methods such as radio frequency ablation or cryo-
therapy. This choice relies on the fact that, as compared with
thermal ablation, radical resection has been shown to reduce
recurrence and improve survival.24
Among the studies on the risk factors of BL after a hepatectomy,
only a single retrospective study reported, in univariate analysis,
an increase of BL in R1 and R2 surgery.25 This may be related to
injuries to major Glissonian sheaths when attempting resection of
adherent or invasive lesions. Another explanation would be per-
sistent tumour tissue at the cut surface, forming a brittle zone with
biliary alterations which is the source of leaks.
The methylene blue test was associated with a reduced inci-
dence of BL. This was in line with the results of Lam et al.5 who
analysed BL in a series of 616 consecutive liver resections for
malignant or benign tumours. In this study, the methylene blue
test was performed on 304 patients (49%) and was associated with
a significant reduction in BL incidence. However, the value of
intra-operative tests to prevent BL is still debated.26,27 Indeed, it
has been argued that dye tests do not check for leaks from
excluded segments and that the injection of dye through the cystic
duct could be responsible for barotrauma which can break the
fragile ligatures and ultimately create a leak or be the cause of
reflux cholangitis.28 Moreover, a dye test makes it necessary to
perform a cholecystectomy which is not always necessary in minor
or wedge liver resections, may not be feasible during iterative liver
resection and has a specific morbidity.29
Conclusion
BL is still common after a hepatectomy and it prolongs hospitali-
zation and alters survival. The advent of biotherapies and the
complexity of the strategies are risk factors.
Table 7 Predictive factors of bile leakage: univariate analysis
Factor Without BL
(n = 921)
With BL
(n = 80)
P
Pre-operative factors
Age >75 years 144 8 0.197
Recent chemotherapy 319 47 <10-3
Associated biotherapy 117 20 <10-3
Bevacizumab 74 19 <10-3
Portal vein embolization 99 13 0.139
Intra-operative factors
Laparotomy 879 80 0.043
Duration of surgery
(min)(min-max)
155
(30–620)
202
(90–480)
<10-3
Two-stage hepatectomy 49 13 0.001
Repeat hepatectomy 159 24 0.016
Blood transfusion 193 31 <10-3
Major hepatectomy 481 58 <10-3
Non-anatomical hepatectomy 225 16 0.13
Right hepatectomy+segment 1 15 4 0.058
Extended right hepatectomy+
segment 1
7 4 0.008
Left hepatectomy+segment 1 19 5 0.036
Segment 3 12 3 0.111
Segment 5 12 3 0.111
Segment 6 18 4 0.092
Right posterior
sectionectomy
53 1 0.117
Wedge of segment 1 14 3 0.148
Portal vein ligation 35 7 0.072
Intra-operative
radiofrequency
40 7 0.092
Vascular-associated resection 16 4 0.068
Venous resection 14 4 0.049
Portal vein resection 5 3 0.021
Selective clamping 87 15 0.042
Pedicular clamping (min-max) 26
(1–110)
29.5
(3–91)
0.091
Vena caval clamping
(min-max)
25
(1–85)
16
(2–37)
0.056
No methylene blue test 470 50 0.061
Raw cut treatment 234 30 0.024
Fibrin glue 78 15 0.007
Surgical drain 823 77 0.052
Anatomopathological factors
Metastasis 457 47 0.13
Resection R1 or R2 120 25 <10-3
BL, bile leakage.
Table 8 Predictive factors of bile leakage: multivariate analysis
Factor OR 95% CI
Use of bevacizumab 2.92 1.58–5.41
Major resection 2.65 1.48–4.76
R1 or R2 resection 2.65 1.52–4.64
Selective clamping 2.65 1.03–6.78
Absence of the methylene blue test 2.57 1.43–4.65
Two-stage surgery 2.55 1.17–5.52
OR, odds ratio; CI, confidence interval.
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The methylene blue test could be a good way to reduce the
incidence of BL.
Bevacizumab is the only biotherapy that has obtained market-
ing authorization for the first-line treatment of liver metastases
of colorectal cancer. In our hands, its administration was associ-
ated with an increased risk of BL, an observation that raises the
question of the time interval between the end of administration of
bevacizumab and liver resection.
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